[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sultan 1. Murat State Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":110},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,66,85],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100633955","tactile-and-pain-sensory-thresholds-and-hand-grip-strength-100633955",false,"NCT07533409","Tactile and Pain Sensory Thresholds and Hand Grip Strength","Comparison of Tactile and Pain Sensory Thresholds and Hand Grip Strength in Children Diagnosed With Specific Learning Disorder With Impairment in Written Expression and Healthy Controls","Inclusion Criteria for specific learning disorder with impairment in written expression:\n\n* Diagnosis of specific learning disorder with impairment in written expression according to the DSM-5 diagnostic criteria\n* Age between 6 and 12 years\n* Clinically normal intellectual functioning\n* Voluntary agreement to participate in the study\n* Absence of any systemic disease\n* Right-hand dominance\n\nInclusion Criteria for control:\n\n* Age between 6 and 12 years\n* Clinically normal intellectual functioning\n* Willingness to participate in the study on a voluntary basis\n* Absence of any systemic disease\n* Right-hand dominance\n\nExclusion Criteria for specific learning disorder with impairment in written expression:\n\n* Presence of verbal or visual communication problems\n* History of perinatal complications or physical head trauma\n* Presence of psychiatric disorders other than specific learning disorder according to the DSM-5 diagnostic criteria\n* History of known chronic physical or neurological disease (such as cerebral palsy, diabetes, epilepsy, autoimmune disease, liver failure, or kidney failure)\n* Presence of substance or alcohol use disorder\n* Diagnosis of a genetic disorder\n* Previous surgery involving the hand region\n* Presence of infection and\u002For sensory deficit in the hand region\n\nExclusion Criteria for control:\n\n* Presence of any psychiatric disorder according to the DSM-5 diagnostic criteria\n* Presence of verbal or visual communication problems\n* History of perinatal complications or physical head trauma\n* History of known chronic physical or neurological disease (such as cerebral palsy, diabetes, epilepsy, autoimmune disease, liver failure, or kidney failure)\n* Presence of substance or alcohol use disorder\n* Diagnosis of a genetic disorder\n* Previous surgery involving the hand region\n* Presence of infection and\u002For sensory deficit in the hand region",true,"ALL","6 Years","12 Years",{"count":21,"type":22},66,"ESTIMATED","OBSERVATIONAL","The aim of this study was to compare fingertip tactile sensation, hand and finger grip strength, and hand pain thresholds in children diagnosed with specific learning disorder with impairment in written expression and healthy controls.",[26,27,28],"Sensation Diminished, Pinprick","Pain","Specific Learning Disorder, With Impairment in Written Expression","RECRUITING","2026-04-09",{"date":32,"type":33},"2026-04-16","ACTUAL",{"date":35,"type":33},"2026-04-10",{"date":37,"type":22},"2026-09-10",{"name":39,"class":40},"Sultan 1. Murat State Hospital","OTHER_GOV",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":63,"leadSponsor":65,"locationsCount":41},"100630436","treatment-response-in-patients-with-medication-overuse-headache-100630436","NCT07487649","Treatment Response in Patients With Medication-Overuse Headache","Factors Affecting Treatment Response in Patients With Medication-Overuse Headache Undergoing Greater Occipital Nerve Blockade","Inclusion Criteria:\n\n* Age between 18 and 65 years\n* Diagnosis of medication-overuse headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)\n* Diagnosis of medication-overuse headache associated with the use of triptans or nonsteroidal anti-inflammatory drugs\n* Previous diagnosis of chronic migraine or chronic tension-type headache according to the ICHD-3 criteria\n\nExclusion Criteria:\n\n* History of severe head or neck trauma or previous neurosurgical intervention\n* Presence of a severe psychiatric disorder (e.g., severe depression, schizophrenia)\n* History of infectious disease, chronic inflammatory disease, or malignancy\n* Previous diagnosis of secondary headache\n* History of substance abuse\n* Pregnancy or breastfeeding\n* History of an additional neurological disorder (e.g., cerebrovascular disease, multiple sclerosis)\n* Difficulty with cooperation\n* Presence of a concomitant systemic disease that may affect quality of life (e.g., congestive heart failure, chronic kidney disease, chronic liver disease, pulmonary disease, uncontrolled diabetes, or peripheral vascular disease)","18 Years","65 Years",{"count":52,"type":22},70,"The aim of this study to evaluate pre-injection patient-related factors that may influence treatment response in patients with medication-overuse headache who underwent ultrasound-guided greater occipital nerve block.",[55,56,57,58],"Medication-overuse Headache","Treatment","Headache","Greater Occipital Nerve Block","2026-03-17",{"date":61,"type":33},"2026-03-23",{"date":59,"type":33},{"date":64,"type":22},"2026-05-30",{"name":39,"class":40},{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":4,"eligibilityCriteria":72,"healthyVolunteers":11,"sex":17,"minAge":73,"maxAge":4,"enrollmentInfo":74,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":76,"conditions":77,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":80,"startDateStruct":81,"completionDateStruct":82,"leadSponsor":84,"locationsCount":41},"100630433","relationship-between-neuropathic-pain-and-geriatric-assessment-parameters-in-patients-aged-80-years-and-older-100630433","NCT07487610","Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older","Evaluation of the Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older","Inclusion Criteria:\n\n* Age 80 years or older\n* Full cooperation\n* Complete comprehensive geriatric assessment parameters\n\nExclusion Criteria:\n\n* Patients with dementia classified as CDR-2 or CDR-3 according to the Clinical Dementia Rating (CDR) Scale\n* Patients who have experienced an acute illness within the last 1 month (e.g., infection, fracture, or cerebrovascular disease)\n* Patients with a psychotic disorder\n* Patients with severe hearing loss\n* Patients with a history of malignancy","80 Years",{"count":75,"type":22},450,"This study aimed to determine the frequency of neuropathic pain in individuals aged 80 years and older and to evaluate the relationship between neuropathic pain and comprehensive geriatric assessment parameters.",[78,79,27],"Neuropathic Pain","Old Age; Debility",{"date":61,"type":33},{"date":59,"type":33},{"date":83,"type":22},"2026-06-30",{"name":39,"class":40},{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":4,"eligibilityCriteria":91,"healthyVolunteers":11,"sex":92,"minAge":49,"maxAge":93,"enrollmentInfo":94,"targetDuration":96,"studyType":23,"phases":4,"briefSummary":97,"conditions":98,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":41},"100618142","fibromyalgia-disease-burden-in-mothers-of-children-with-attention-deficithyperactivity-disorder-100618142","NCT07327775","Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit\u002FHyperactivity Disorder","Is the Disease Burden of Fibromyalgia Syndrome Higher in Mothers of Children With Attention-Deficit\u002FHyperactivity Disorder? A Prospective Controlled Study","Inclusion Criteria:\n\nInclusion Criteria for Participants with Children Diagnosed with ADHD:\n\n* Being a female aged between 18 and 50 years\n* Having one or more children aged 6-17 years diagnosed with Attention Deficit\u002FHyperactivity Disorder (ADHD) according to DSM-5 diagnostic criteria\n* Having a diagnosis of Fibromyalgia Syndrome (FMS according to the 2016 American College of Rheumatology \\[ACR\\] criteria)\n* Being literate\n\nInclusion Criteria for Participants with Children Without Psychiatric Disorders:\n\n* Being a female aged between 18 and 50 years\n* Having one or more children aged 6-17 years without any psychiatric disorders\n* Having a diagnosis of Fibromyalgia Syndrome (FMS) according to the 2016 American College of Rheumatology (ACR) criteria\n* Being literate\n\nExclusion Criteria:\n\n* Receiving regular pharmacological treatment for Fibromyalgia Syndrome\n* Having an active psychiatric disorder or using psychiatric medication\n* Having a history of infectious disease, chronic inflammatory disease, or malignancy\n* Being pregnant or breastfeeding\n* Having a central or peripheral nervous system disorder (e.g., cerebrovascular disease, multiple sclerosis)\n* Being uncooperative during clinical evaluation\n* Having comorbid conditions that may affect quality of life, including congestive heart failure, chronic kidney disease, chronic liver disease, pulmonary disease, uncontrolled diabetes mellitus, or peripheral vascular disease\n* Having a diagnosis of hypothyroidism or hyperthyroidism\n* Having substance use disorder or alcohol use disorder","FEMALE","50 Years",{"count":95,"type":22},100,"1 Day","In this study, the investigators aimed to evaluate the impact of having a child diagnosed with Attention-Deficit\u002FHyperactivity Disorder (ADHD) on parental disease burden in mothers diagnosed with Fibromyalgia Syndrome (FMS).\n\nThe study will include 50 mothers with FMS who have a child diagnosed with ADHD and 50 mothers with FMS who have children without any psychiatric disorders.\n\nAmong mothers of children followed with a diagnosis of ADHD at the Child and Adolescent Psychiatry Outpatient Clinic of Edirne Sultan 1st Murat State Hospital, the presence of widespread body pain will be assessed. Mothers reporting widespread body pain will be referred to the Pain Management Outpatient Clinic of the same hospital for further evaluation for FMS. Mothers diagnosed with FMS will be included in the study group.\n\nThe comparison group will consist of mothers with FMS who have children without any psychiatric disorders. These participants will be selected from patients diagnosed with FMS who present to the Pain Management Outpatient Clinic of Edirne Sultan 1st Murat State Hospital.",[99,100,101],"Fibromyalgia Syndrome","Disease Burden","Attention-Deficit\u002FHyperactivity Disorder","2026-01-08",{"date":104,"type":33},"2026-01-12",{"date":106,"type":33},"2025-12-26",{"date":108,"type":22},"2026-04-30",{"name":39,"class":40},""]